{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T17:57:32Z","timestamp":1791395852156,"version":"4.3.3"},"reference-count":30,"publisher":"Massachusetts Medical Society","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["N Engl J Med"],"published-print":{"date-parts":[[2026,7,30]]},"DOI":"10.1056\/nejmoa2602910","type":"journal-article","created":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T21:00:15Z","timestamp":1785358815000},"page":"454-464","source":"Crossref","is-referenced-by-count":3,"title":["Phase 2b Trial of a Na\n                    <sub>V<\/sub>\n                    1.8 Inhibitor for Acute Pain"],"prefix":"10.1056","volume":"395","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7107-331X","authenticated-orcid":false,"given":"Neil","family":"Singla","sequence":"first","affiliation":[{"name":"Latigo Biotherapeutics, Thousand Oaks, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathaniel P.","family":"Katz","sequence":"additional","affiliation":[{"name":"Ein Sof Innovation, Boston"},{"name":"Vital Clinical Solutions, Boston"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ben","family":"Vaughn","sequence":"additional","affiliation":[{"name":"Latigo Biotherapeutics, Thousand Oaks, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy","family":"Rogier","sequence":"additional","affiliation":[{"name":"Latigo Biotherapeutics, Thousand Oaks, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Todd","family":"Bertoch","sequence":"additional","affiliation":[{"name":"CenExel, Salt Lake City"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harold","family":"Minkowitz","sequence":"additional","affiliation":[{"name":"Evolution Research Group Research, New Providence, NJ"},{"name":"University of Texas M.D. Anderson Cancer Center, Houston"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mallory","family":"Loflin","sequence":"additional","affiliation":[{"name":"Latigo Biotherapeutics, Thousand Oaks, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"150","reference":[{"key":"e_1_3_5_2_2","doi-asserted-by":"publisher","DOI":"10.2147\/IJGM.S419239"},{"key":"e_1_3_5_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpain.2015.12.008"},{"key":"e_1_3_5_4_2","doi-asserted-by":"publisher","DOI":"10.1097\/SLA.0000000000001993"},{"key":"e_1_3_5_5_2","doi-asserted-by":"publisher","DOI":"10.1097\/SLA.0000000000002969"},{"key":"e_1_3_5_6_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00266-021-02494-y"},{"key":"e_1_3_5_7_2","doi-asserted-by":"publisher","DOI":"10.1093\/asj\/sjad381"},{"key":"e_1_3_5_8_2","doi-asserted-by":"publisher","DOI":"10.1080\/17581869.2024.2442292"},{"key":"e_1_3_5_9_2","unstructured":"AHFS patient medication information: suzetrigine. Bethesda MD: American Society of Health-System Pharmacists 2025 (https:\/\/medlineplus.gov\/druginfo\/meds\/a625039.html)."},{"key":"e_1_3_5_10_2","doi-asserted-by":"publisher","DOI":"10.1152\/physrev.00052.2017"},{"key":"e_1_3_5_11_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000002333"},{"key":"e_1_3_5_12_2","doi-asserted-by":"publisher","DOI":"10.1007\/s40122-024-00697-0"},{"key":"e_1_3_5_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2025.118326"},{"key":"e_1_3_5_14_2","first-page":"1085","article-title":"Suzetrigine, a nonopioid Nav1.8 inhibitor for treatment of moderate-to-severe acute pain: two phase 3 randomized clinical trials.","volume":"142","author":"Bertoch T","year":"2025","unstructured":"Bertoch T, D\u2019Aunno D, McCoun J, et al. Suzetrigine, a nonopioid Nav1.8 inhibitor for treatment of moderate-to-severe acute pain: two phase 3 randomized clinical trials. Anesthesiology 2025;142:1085-1099.40117446","journal-title":"Anesthesiology"},{"key":"e_1_3_5_15_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2209870"},{"key":"e_1_3_5_16_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmjmed-2025-001431"},{"key":"e_1_3_5_17_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMe2305480"},{"key":"e_1_3_5_18_2","unstructured":"Vertex announces results from phase 2 study of VX-993 for the treatment of acute pain. News release of Vertex Pharmaceuticals Boston August 4 2025 (https:\/\/investors.vrtx.com\/news-releases\/news-release-details\/vertex-announces-results-phase-2-study-vx-993-treatment-acute)."},{"key":"e_1_3_5_19_2","doi-asserted-by":"publisher","DOI":"10.1097\/j.pain.0000000000002736"},{"key":"e_1_3_5_20_2","doi-asserted-by":"publisher","DOI":"10.1093\/asj\/sjad117"},{"key":"e_1_3_5_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpain.2015.03.004"},{"key":"e_1_3_5_22_2","doi-asserted-by":"publisher","DOI":"10.1136\/rapm-2020-101670"},{"key":"e_1_3_5_23_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2044.1998.00294.x"},{"key":"e_1_3_5_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0885-3924(03)00162-3"},{"key":"e_1_3_5_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.pain.2009.08.019"},{"key":"e_1_3_5_26_2","doi-asserted-by":"publisher","DOI":"10.1007\/s40268-020-00309-0"},{"key":"e_1_3_5_27_2","doi-asserted-by":"publisher","DOI":"10.1097\/GOX.0000000000001846"},{"key":"e_1_3_5_28_2","doi-asserted-by":"publisher","DOI":"10.1002\/ejp.536"},{"key":"e_1_3_5_29_2","unstructured":"Porras H Lammer C. Patient safety events involving opioid dose stacking. In: WebM&M: case studies. Rockville MD: Agency for Healthcare Research and Quality January 26 2022."},{"key":"e_1_3_5_30_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejpain.2004.01.003"},{"key":"e_1_3_5_31_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.pain.2010.11.030"}],"container-title":["New England Journal of Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nejm.org\/doi\/pdf\/10.1056\/NEJMoa2602910","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T21:00:19Z","timestamp":1785358819000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.nejm.org\/doi\/10.1056\/NEJMoa2602910"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,30]]},"references-count":30,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,7,30]]}},"alternative-id":["10.1056\/NEJMoa2602910"],"URL":"https:\/\/doi.org\/10.1056\/nejmoa2602910","relation":{},"ISSN":["0028-4793","1533-4406"],"issn-type":[{"value":"0028-4793","type":"print"},{"value":"1533-4406","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,30]]}}}